Presentation is loading. Please wait.

Presentation is loading. Please wait.

UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

Published byBriana Byrd Modified over 8 years ago

Similar presentations

Presentation on theme: "UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit."— Presentation transcript:

1 UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit measure (1.1– 1.7 mmol/L) by centre in 2013

2 UK Renal Registry 17th Annual Report Figure 8.2. Funnel plot of percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit measure (1.1–1.7 mmol/L) by centre in 2013

3 UK Renal Registry 17th Annual Report Figure 8.3. Percentage of peritoneal dialysis patients with phosphate within the range specified by the RA clinical audit measure (1.1–1.7 mmol/L) by centre in 2013

4 UK Renal Registry 17th Annual Report Figure 8.4. Funnel plot of percentage of peritoneal dialysis patients with phosphate within the range specified by the RA clinical audit measure (1.1–1.7 mmol/L) by centre in 2013

5 UK Renal Registry 17th Annual Report Figure 8.5. Longitudinal change in percentage of patients with phosphate below, within and above the 2010 RA standard by dialysis modality 2003–2013

6 UK Renal Registry 17th Annual Report Figure 8.6. Percentage of haemodialysis patients with adjusted calcium within range (2.2–2.5 mmol/L) by centre in 2013

7 UK Renal Registry 17th Annual Report Figure 8.7. Funnel plot of percentage of haemodialysis patients with adjusted calcium within range (2.2–2.5 mmol/L) by centre in 2013

8 UK Renal Registry 17th Annual Report Figure 8.8. Percentage of peritoneal dialysis patients with adjusted calcium within range (2.2–2.5 mmol/L) by centre in 2013

9 UK Renal Registry 17th Annual Report Figure 8.9. Funnel plot of percentage of peritoneal dialysis patients with adjusted calcium within range (2.2–2.5 mmol/L) by centre in 2013

10 UK Renal Registry 17th Annual Report Figure 8.10. Longitudinal change in percentage of patients with adjusted calcium 2.5 mmol/L by dialysis modality 2003–2013

11 UK Renal Registry 17th Annual Report Figure 8.11. Percentage of haemodialysis patients with PTH within range (16–72 pmol/L) by centre in 2013

12 UK Renal Registry 17th Annual Report Figure 8.12. Funnel plot of percentage of haemodialysis patients with PTH within range (16–72 pmol/L) by centre in 2013

13 UK Renal Registry 17th Annual Report Figure 8.13. Percentage of peritoneal dialysis patients with PTH within range (16–72 pmol/L) by centre in 2013

14 UK Renal Registry 17th Annual Report Figure 8.14. Funnel plot of percentage of peritoneal dialysis patients with PTH within range (16–72 pmol/L) by centre in 2013

15 UK Renal Registry 17th Annual Report Figure 8.15. Longitudinal change in percentage of patients with PTH within range (16–72 pmol/L) by dialysis modality 2003–2013

16 UK Renal Registry 17th Annual Report Figure 8.16. Percentage of HD patients achieving simultaneous control of all three BMD parameters in preventing severe hyperparathyroidism by centre in 2013

17 UK Renal Registry 17th Annual Report Figure 8.17. Percentage of PD patients achieving simultaneous control of all three BMD parameters in preventing severe hyperparathyroidism by centre in 2013

18 UK Renal Registry 17th Annual Report Figure 8.18. Funnel plot for percentage of HD patients achieving simultaneous control of all three BMD parameters in preventing severe hyperparathyroidism by centre in 2013

19 UK Renal Registry 17th Annual Report Figure 8.19. Funnel plot for percentage of PD patients achieving simultaneous control of all three BMD parameters in preventing severe hyperparathyroidism by centre in 2013

20 UK Renal Registry 17th Annual Report Figure 8.20. Percentage of haemodialysis patients with serum bicarbonate within range (18–24 mmol/L) by centre in 2013

21 UK Renal Registry 17th Annual Report Figure 8.21. Funnel plot for percentage of haemodialysis patients within the range for bicarbonate (18–24 mmol/L) by centre in 2013

22 UK Renal Registry 17th Annual Report Figure 8.22. Percentage of peritoneal dialysis patients with serum bicarbonate within range (22–30 mmol/L) by centre in 2013

23 UK Renal Registry 17th Annual Report Figure 8.23. Funnel plot for percentage of peritoneal dialysis patients within the range for bicarbonate (22–30 mmol/L) by centre in 2013

24 UK Renal Registry 17th Annual Report Figure 8.24. Longitudinal change in percentage of patients within the range for bicarbonate (18–24 mmol/L for HD and 22–30 mmol/L for PD) by dialysis modality 2003–2013

Download ppt "UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit."

Similar presentations

UK Renal Registry 13th Annual Report Figure 12.1: Median height z-scores for transplant patients in 2009.

UK Renal Registry 13th Annual Report Figure 12.1: Median height z-scores for transplant patients in 2009.
The effect of organisational factors and processes of care on between centre achievement of audit measures for calcium, phosphate and PTH in UK haemodialysis.

The effect of organisational factors and processes of care on between centre achievement of audit measures for calcium, phosphate and PTH in UK haemodialysis.
UK Renal Registry 16th Annual Report Figure 14.1. Data completeness for key variables, stratified by first modality HD = haemodialysis; PD = peritoneal.

UK Renal Registry 16th Annual Report Figure Data completeness for key variables, stratified by first modality HD = haemodialysis; PD = peritoneal.
UK Renal Registry 17th Annual Report Figure 10.1. Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.

UK Renal Registry 17th Annual Report Figure Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.
UK Renal Registry 15th Annual Report Figure 5.26. One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.

UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
UK Renal Registry 15th Annual Report Figure 8.1. Age and gender of PD patients submitted to audit.

UK Renal Registry 15th Annual Report Figure 8.1. Age and gender of PD patients submitted to audit.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.

UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients

UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure 10.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.

UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.

UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UK Renal Registry 17th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2013.

UK Renal Registry 17th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2013.
UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.

UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.
UK Renal Registry 9 th Annual Report 2006 Fig 9.1 Percentage of patients with serum phosphate

UK Renal Registry 9 th Annual Report 2006 Fig 9.1 Percentage of patients with serum phosphate
UK Renal Registry 17th Annual Report Figure 11.1. Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.

UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
Scottish Renal Registry Report 2009 Published by the Information Services Division (ISD Scotland), Common Services Agency for NHSScotland, 1 South Gyle.

Scottish Renal Registry Report 2009 Published by the Information Services Division (ISD Scotland), Common Services Agency for NHSScotland, 1 South Gyle.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.

UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK: 1990-2006.

UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
UK Renal Registry 9 th Annual Report 2006 Fig 10.1 Systolic BP mm Hg (pre-HD)

UK Renal Registry 9 th Annual Report 2006 Fig 10.1 Systolic BP mm Hg (pre-HD)
UK Renal Registry 16th Annual Report Figure 11.1. Summary of BP achievements.

UK Renal Registry 16th Annual Report Figure Summary of BP achievements.
UK Renal Registry 14th Annual Report Figure 10.1. Summary of BP achievements.

UK Renal Registry 14th Annual Report Figure Summary of BP achievements.

Similar presentations

Ads by Google